Analytical Data
-
Gene name
PLEKHF2
- Application
-
Alternative Names
Endoplasmic reticulum-associated apoptosis-involved protein containing PH and FYVE domains
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H8W4
-
Expression Region
1-249aa
-
Molecular Weight
54.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PLEKHF2, a member of the pleckstrin homology (PH) domain-containing family, has garnered increasing attention due to its potential role in cellular signaling and its involvement in various biological processes. Recent studies suggest that PLEKHF2 is implicated in key pathways related to immune response, cell morphogenesis, and neuronal development, highlighting its importance in both health and disease. The protein's unique structure, characterized by a PH domain that interacts with phosphoinositides, allows it to play a critical role in membrane trafficking and cytoskeletal dynamics. Given the growing evidence linking PLEKHF2 to important cellular functions, researchers have focused on characterizing its biochemical properties and elucidating its molecular interactions. Recombinant PLEKHF2 has been developed to facilitate in-depth studies, enabling researchers to investigate its functional roles and regulatory mechanisms. The study of PLEKHF2 is particularly relevant in the context of diseases such as cancer and neurodegenerative disorders, as understanding its function may provide insights into therapeutic targets and novel treatment strategies. Thus, the research on PLEKHF2 recombinant protein not only sheds light on fundamental biological processes but also opens avenues for clinical applications, emphasizing its significance in biomedical research.
